Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 16.61% is 60% above its 5-year average of 10.40%, near the high end of its 5-year range (5.32%–16.61%).
As of the fiscal period ended Wednesday, December 31, 2025. 32.25% above its 12-month average of 12.56%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
16.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
12.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
12.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
10.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
10.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
11.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
14.07%
CURRENT VS TTM AVG
+32.25%
CURRENT VS 3Y AVG
+32.59%
CURRENT VS 5Y AVG
+59.74%
CURRENT VS 10Y AVG
+63.92%
CURRENT VS 15Y AVG
+43.61%
CURRENT VS 20Y AVG
+18.06%
SECTOR MEDIAN · HEALTHCARE
8.78%
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
+89.18%
vs the sector median at left
GSK plc
Market Cap
$102.00B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
12.56%
3Y Avg
12.53%
5Y Avg
10.40%
Market Cap
$105.58B
Return on Invested Capital (ROIC)
31.48%
TTM Avg
27.39%
3Y Avg
24.73%
5Y Avg
20.68%
Market Cap
$89.11B
Return on Invested Capital (ROIC)
18.53%
TTM Avg
17.61%
3Y Avg
17.07%
5Y Avg
16.89%
Market Cap
$116.01B
Return on Invested Capital (ROIC)
6.13%
TTM Avg
6.11%
3Y Avg
5.46%
5Y Avg
5.53%
Market Cap
$119.31B
Return on Invested Capital (ROIC)
4.72%
TTM Avg
4.17%
3Y Avg
4.46%
5Y Avg
4.93%
Market Cap
$84.66B
Return on Invested Capital (ROIC)
6.65%
TTM Avg
6.70%
3Y Avg
7.11%
5Y Avg
7.33%
Market Cap
$82.11B
Return on Invested Capital (ROIC)
8.51%
TTM Avg
9.70%
3Y Avg
12.91%
5Y Avg
18.22%
Market Cap
$76.09B
Return on Invested Capital (ROIC)
8.78%
TTM Avg
7.46%
3Y Avg
6.12%
5Y Avg
5.55%
Market Cap
$129.95B
Return on Invested Capital (ROIC)
15.03%
TTM Avg
14.31%
3Y Avg
12.21%
5Y Avg
10.36%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GSK plc (GSK) | $102.00B | 16.61% | 12.56% | 12.53% | 10.40% |
| McKesson Corporation (MCK)vs › | $105.58B | 31.48% | 27.39% | 24.73% | 20.68% |
| HCA Healthcare, Inc. (HCA)vs › | $89.11B | 18.53% | 17.61% | 17.07% | 16.89% |
| Medtronic plc (MDT)vs › | $116.01B | 6.13% | 6.11% | 5.46% | 5.53% |
| CVS Health Corp. (CVS)vs › | $119.31B | 4.72% | 4.17% | 4.46% | 4.93% |
| Elevance Health Inc. (ELV)vs › | $84.66B | 6.65% | 6.70% | 7.11% | 7.33% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $82.11B | 8.51% | 9.70% | 12.91% | 18.22% |
| Boston Scientific Corporation (BSX)vs › | $76.09B | 8.78% | 7.46% | 6.12% | 5.55% |
| Bristol-Myers Squibb Company (BMY)vs › | $129.95B | 15.03% | 14.31% | 12.21% | 10.36% |
| Cigna Corporation (CI)vs › | $72.36B | 7.35% | 7.02% | 7.07% | 6.50% |
ROIC
16.6%
ROE
27.7%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 16.61% |
| 2024-12-31 | 8.51% |
| 2023-12-31 | 11.37% |
| 2022-12-31 | 13.62% |
| 2021-12-31 | 5.32% |
| 2020-12-31 | 6.96% |
| 2019-12-31 | 7.11% |
| 2018-12-31 | 11.17% |
| 2017-12-31 | 7.71% |
| 2016-12-31 | 3.22% |
| 2015-12-31 | 19.86% |
| 2014-12-31 | 11.32% |
| 2013-12-31 | 19.07% |
| 2012-12-31 | 16.50% |
| 2011-12-31 | 19.24% |
| 2010-12-31 | 7.47% |
| 2009-12-31 | 18.79% |
| 2008-12-31 | 16.66% |
| 2007-12-31 | 23.46% |
| 2006-12-31 | 26.65% |
| 2005-12-31 | 24.83% |
| 2004-12-31 | 23.05% |
| 2003-12-31 | 27.54% |
| 2002-12-31 | 27.06% |
| 2001-12-31 | 30.38% |
| 2000-12-31 | 22.71% |
| 1999-12-31 | 25.15% |
| 1998-12-31 | 28.60% |
| 1997-12-31 | 34.22% |
| 1996-12-31 | 37.61% |
